NAD might just help you finish strong
Diabetes Care 37:912921 Greenway FL, Fujioka K, Plodkowski RA et al (2010) Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
Imagine this: you go to your doctor to talk about weight loss, expecting a conversation about blood sugar, diet tweaks, and maybe a prescription for one of those new GLP-1 injections you keep hearing about
An 8-week cycle might follow this pattern: 2 weeks introduction, 4 weeks optimization, 2 weeks maintenance
Even if GLP-1 increases, the downstream effects on appetite and weight depend on receptor sensitivity, metabolic rate, caloric intake, and dozens of other factors